Ursula Matulonis
1Dana-Farber Cancer Institute

Last Updated On 1/23/2026 3:39:31 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
Company: Symphogen
Recipient: You
Company: Macrogenics
Recipient: You
Company: AstraZeneca
Recipient: You
Company: Daiichi Sankyo/Astra Zeneca
Recipient: You

Consulting or Advisory Role
Company: Merck
Recipient: You
Company: NextCure
Recipient: You
Company: Immunogen
Recipient: You
Company: Profound Bio
Recipient: You
Company: GSK
Recipient: You
Company: Tango Therapeutics
Recipient: You
Company: Day One Therapeutics
Recipient: You
Company: Whitehawk Therapeutics
Recipient: You
Company: Daiichi Sankyo/Astra Zeneca
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
No Relationships to Disclose

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose